carbamates has been researched along with Binge-Eating Disorder in 1 studies
Binge-Eating Disorder: A disorder associated with three or more of the following: eating until feeling uncomfortably full; eating large amounts of food when not physically hungry; eating much more rapidly than normal; eating alone due to embarrassment; feeling of disgust, DEPRESSION, or guilt after overeating. Criteria includes occurrence on average, at least 2 days a week for 6 months. The binge eating is not associated with the regular use of inappropriate compensatory behavior (i.e. purging, excessive exercise, etc.) and does not co-occur exclusively with BULIMIA NERVOSA or ANOREXIA NERVOSA. (From DSM-IV, 1994)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guerdjikova, AI | 1 |
| Romo-Nava, F | 1 |
| Blom, TJ | 1 |
| Mori, N | 1 |
| McElroy, SL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Solriamfetol in Binge Eating Disorder[NCT04602936] | Phase 4 | 64 participants (Anticipated) | Interventional | 2021-06-15 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for carbamates and Binge-Eating Disorder
| Article | Year |
|---|---|
Study protocol and rationale for a randomized, placebo-controlled trial of solriamfetol to treat binge eating disorder.
Topics: Binge-Eating Disorder; Carbamates; Double-Blind Method; Humans; Phenylalanine; Randomized Controlled | 2021 |